Application 209489
- Type
- ANDA
- Sponsor
- CIPLA
Application Products#
| Product | Drug | Ingredient | Form | Strength | Reference drug | Reference standard |
|---|---|---|---|---|---|---|
| 001 | CASPOFUNGIN ACETATE | CASPOFUNGIN ACETATE | POWDER;INTRAVENOUS | 50MG/VIAL | No | No |
| 002 | CASPOFUNGIN ACETATE | CASPOFUNGIN ACETATE | POWDER;INTRAVENOUS | 70MG/VIAL | No | No |
Orange Book products#
| Application-product | Trade name | Ingredient | Strength | Dosage form / route | TE codes | RLD / RS | Approval date |
|---|---|---|---|---|---|---|---|
| A209489-001 | CASPOFUNGIN ACETATE | CASPOFUNGIN ACETATE | 50MG/VIAL | POWDER / INTRAVENOUS | 2018-07-12 | ||
| A209489-002 | CASPOFUNGIN ACETATE | CASPOFUNGIN ACETATE | 70MG/VIAL | POWDER / INTRAVENOUS | 2018-07-12 |
Observed Orange Book product history#
Observed FDA ZIP history: Each table is queried independently by exact application/product key from successfully parsed Orange Book snapshots. Capture times identify archived source observations; absence or a change between snapshots is not inferred. FDA publication files that were not recoverable as structured ZIP data are not represented as states.
| Captured | Edition | Application-product | Trade name | Strength | Dosage form / route | Product TE source text | RLD / RS | Approval date | Source SHA-256 |
|---|---|---|---|---|---|---|---|---|---|
| 2019-12-13 00:20 UTC | 2019-12 | A209489-001 | CASPOFUNGIN ACETATE | 50MG/VIAL | POWDER / INTRAVENOUS | 2018-07-12 | 74a2ff9319b5… | ||
| 2019-12-13 00:20 UTC | 2019-12 | A209489-002 | CASPOFUNGIN ACETATE | 70MG/VIAL | POWDER / INTRAVENOUS | 2018-07-12 | 74a2ff9319b5… | ||
| 2022-03-09 01:35 UTC | 2022-03 | A209489-001 | CASPOFUNGIN ACETATE | 50MG/VIAL | POWDER / INTRAVENOUS | 2018-07-12 | bb7c543d1eb4… | ||
| 2022-03-09 01:35 UTC | 2022-03 | A209489-002 | CASPOFUNGIN ACETATE | 70MG/VIAL | POWDER / INTRAVENOUS | 2018-07-12 | bb7c543d1eb4… | ||
| 2021-12-28 21:50 UTC | 2021-12 | A209489-001 | CASPOFUNGIN ACETATE | 50MG/VIAL | POWDER / INTRAVENOUS | 2018-07-12 | 782e0a99824c… | ||
| 2021-12-28 21:50 UTC | 2021-12 | A209489-002 | CASPOFUNGIN ACETATE | 70MG/VIAL | POWDER / INTRAVENOUS | 2018-07-12 | 782e0a99824c… | ||
| 2021-05-05 16:15 UTC · 3 captures of this ZIP | 2021-05 | A209489-001 | CASPOFUNGIN ACETATE | 50MG/VIAL | POWDER / INTRAVENOUS | 2018-07-12 | 87673890dc5c… | ||
| 2021-05-05 16:15 UTC · 3 captures of this ZIP | 2021-05 | A209489-002 | CASPOFUNGIN ACETATE | 70MG/VIAL | POWDER / INTRAVENOUS | 2018-07-12 | 87673890dc5c… | ||
| 2021-03-12 10:30 UTC | 2021-03 | A209489-001 | CASPOFUNGIN ACETATE | 50MG/VIAL | POWDER / INTRAVENOUS | 2018-07-12 | 5aa47cf7b7d7… | ||
| 2021-03-12 10:30 UTC | 2021-03 | A209489-002 | CASPOFUNGIN ACETATE | 70MG/VIAL | POWDER / INTRAVENOUS | 2018-07-12 | 5aa47cf7b7d7… | ||
| 2020-12-22 03:56 UTC | 2020-12 | A209489-001 | CASPOFUNGIN ACETATE | 50MG/VIAL | POWDER / INTRAVENOUS | 2018-07-12 | 8869cabd3fbd… | ||
| 2020-12-22 03:56 UTC | 2020-12 | A209489-002 | CASPOFUNGIN ACETATE | 70MG/VIAL | POWDER / INTRAVENOUS | 2018-07-12 | 8869cabd3fbd… | ||
| 2020-11-12 02:37 UTC | 2020-11 | A209489-001 | CASPOFUNGIN ACETATE | 50MG/VIAL | POWDER / INTRAVENOUS | 2018-07-12 | c0c555d07b60… | ||
| 2020-11-12 02:37 UTC | 2020-11 | A209489-002 | CASPOFUNGIN ACETATE | 70MG/VIAL | POWDER / INTRAVENOUS | 2018-07-12 | c0c555d07b60… | ||
| 2019-12-14 00:12 UTC | 2019-12 | A209489-001 | CASPOFUNGIN ACETATE | 50MG/VIAL | POWDER / INTRAVENOUS | 2018-07-12 | 3f01610625f2… | ||
| 2019-12-14 00:12 UTC | 2019-12 | A209489-002 | CASPOFUNGIN ACETATE | 70MG/VIAL | POWDER / INTRAVENOUS | 2018-07-12 | 3f01610625f2… | ||
| 2019-09-15 20:21 UTC | 2019-09 | A209489-001 | CASPOFUNGIN ACETATE | 50MG/VIAL | POWDER / INTRAVENOUS | 2018-07-12 | b00525d2431f… | ||
| 2019-09-15 20:21 UTC | 2019-09 | A209489-002 | CASPOFUNGIN ACETATE | 70MG/VIAL | POWDER / INTRAVENOUS | 2018-07-12 | b00525d2431f… | ||
| 2019-07-19 19:46 UTC | 2019-07 | A209489-001 | CASPOFUNGIN ACETATE | 50MG/VIAL | POWDER / INTRAVENOUS | 2018-07-12 | ea99ee380514… | ||
| 2019-07-19 19:46 UTC | 2019-07 | A209489-002 | CASPOFUNGIN ACETATE | 70MG/VIAL | POWDER / INTRAVENOUS | 2018-07-12 | ea99ee380514… | ||
| 2024-03-16 18:09 UTC · 4 captures of this ZIP | 2024-03 | A209489-001 | CASPOFUNGIN ACETATE | 50MG/VIAL | POWDER / INTRAVENOUS | 2018-07-12 | 6a51e52b5d6a… | ||
| 2024-03-16 18:09 UTC · 4 captures of this ZIP | 2024-03 | A209489-002 | CASPOFUNGIN ACETATE | 70MG/VIAL | POWDER / INTRAVENOUS | 2018-07-12 | 6a51e52b5d6a… | ||
| 2024-02-18 07:12 UTC | 2024-02 | A209489-001 | CASPOFUNGIN ACETATE | 50MG/VIAL | POWDER / INTRAVENOUS | 2018-07-12 | 1c564ffb4f44… | ||
| 2024-02-18 07:12 UTC | 2024-02 | A209489-002 | CASPOFUNGIN ACETATE | 70MG/VIAL | POWDER / INTRAVENOUS | 2018-07-12 | 1c564ffb4f44… | ||
| 2023-12-20 04:57 UTC | 2023-12 | A209489-001 | CASPOFUNGIN ACETATE | 50MG/VIAL | POWDER / INTRAVENOUS | 2018-07-12 | ea1830bbd6c7… | ||
| 2023-12-20 04:57 UTC | 2023-12 | A209489-002 | CASPOFUNGIN ACETATE | 70MG/VIAL | POWDER / INTRAVENOUS | 2018-07-12 | ea1830bbd6c7… | ||
| 2023-11-28 05:40 UTC · 2 captures of this ZIP | 2023-11 | A209489-001 | CASPOFUNGIN ACETATE | 50MG/VIAL | POWDER / INTRAVENOUS | 2018-07-12 | a72a2bbeb626… | ||
| 2023-11-28 05:40 UTC · 2 captures of this ZIP | 2023-11 | A209489-002 | CASPOFUNGIN ACETATE | 70MG/VIAL | POWDER / INTRAVENOUS | 2018-07-12 | a72a2bbeb626… | ||
| 2023-10-25 00:34 UTC · 2 captures of this ZIP | 2023-10 | A209489-001 | CASPOFUNGIN ACETATE | 50MG/VIAL | POWDER / INTRAVENOUS | 2018-07-12 | 9b2671bbb829… | ||
| 2023-10-25 00:34 UTC · 2 captures of this ZIP | 2023-10 | A209489-002 | CASPOFUNGIN ACETATE | 70MG/VIAL | POWDER / INTRAVENOUS | 2018-07-12 | 9b2671bbb829… | ||
| 2023-07-15 15:27 UTC · 2 captures of this ZIP | 2023-07 | A209489-001 | CASPOFUNGIN ACETATE | 50MG/VIAL | POWDER / INTRAVENOUS | 2018-07-12 | a67488948f0b… | ||
| 2023-07-15 15:27 UTC · 2 captures of this ZIP | 2023-07 | A209489-002 | CASPOFUNGIN ACETATE | 70MG/VIAL | POWDER / INTRAVENOUS | 2018-07-12 | a67488948f0b… | ||
| 2023-06-13 01:57 UTC · 3 captures of this ZIP | 2023-06 | A209489-001 | CASPOFUNGIN ACETATE | 50MG/VIAL | POWDER / INTRAVENOUS | 2018-07-12 | 3f0d92c62455… | ||
| 2023-06-13 01:57 UTC · 3 captures of this ZIP | 2023-06 | A209489-002 | CASPOFUNGIN ACETATE | 70MG/VIAL | POWDER / INTRAVENOUS | 2018-07-12 | 3f0d92c62455… | ||
| 2023-05-13 08:27 UTC | 2023-05 | A209489-001 | CASPOFUNGIN ACETATE | 50MG/VIAL | POWDER / INTRAVENOUS | 2018-07-12 | 053a50430f4f… | ||
| 2023-05-13 08:27 UTC | 2023-05 | A209489-002 | CASPOFUNGIN ACETATE | 70MG/VIAL | POWDER / INTRAVENOUS | 2018-07-12 | 053a50430f4f… | ||
| 2023-01-26 05:58 UTC | 2023-01 | A209489-001 | CASPOFUNGIN ACETATE | 50MG/VIAL | POWDER / INTRAVENOUS | 2018-07-12 | 3bdfa0b2c4d7… | ||
| 2023-01-26 05:58 UTC | 2023-01 | A209489-002 | CASPOFUNGIN ACETATE | 70MG/VIAL | POWDER / INTRAVENOUS | 2018-07-12 | 3bdfa0b2c4d7… | ||
| 2022-11-12 20:34 UTC · 5 captures of this ZIP | 2022-11 | A209489-001 | CASPOFUNGIN ACETATE | 50MG/VIAL | POWDER / INTRAVENOUS | 2018-07-12 | 3a93d1ddd44b… | ||
| 2022-11-12 20:34 UTC · 5 captures of this ZIP | 2022-11 | A209489-002 | CASPOFUNGIN ACETATE | 70MG/VIAL | POWDER / INTRAVENOUS | 2018-07-12 | 3a93d1ddd44b… |
openFDA label cross-check#
OpenFDA label data provides additional search and identifier links. DailyMed’s Structured Product Label is the canonical label on FDA.report. Matching records are deduplicated before they are shown below.
| Brand | Generic | Manufacturer | SPL set ID | Effective date | Available safety fields | Join |
|---|---|---|---|---|---|---|
| Caspofungin Acetate | CASPOFUNGIN ACETATE | Sagent Pharmaceuticals | 08fb61ee-a05a-4ce1-934c-8cd26c5733db | 2026-07-29 | Warnings, Adverse reactions | Caspofungin Acetate CASPOFUNGIN ACETATE |
| Caspofungin Acetate | CASPOFUNGIN ACETATE | Fresenius Kabi USA, LLC | e76d8d83-3691-451c-a32c-d91448c54d16 | 2026-01-08 | Warnings, Adverse reactions | Caspofungin Acetate CASPOFUNGIN ACETATE |
| CASPOFUNGIN ACETATE | CASPOFUNGIN ACETATE | Hangzhou Zhongmei Huadong Pharmaceutical Co., Ltd. | 2b9bf716-9d4b-4264-985b-6fe98f5e729d | 2025-10-08 | Warnings, Adverse reactions | CASPOFUNGIN ACETATE CASPOFUNGIN ACETATE |
| CANCIDAS | CASPOFUNGIN ACETATE | Merck Sharp & Dohme LLC | 3bad23a6-09a6-4194-9182-093ed61bc71c | 2024-10-11 | Warnings, Adverse reactions | CASPOFUNGIN ACETATE |
| Caspofungin Acetate | CASPOFUNGIN ACETATE | Fosun Pharma USA Inc. | cbd33696-e059-4e27-a782-95e23e8159b8 | 2022-03-21 | Warnings, Adverse reactions | Caspofungin Acetate CASPOFUNGIN ACETATE |
| CASPOFUNGIN ACETATE | CASPOFUNGIN ACETATE | Sandoz Inc | 722facc6-d4ea-4975-b83e-3ae63df69ed2 | 2022-01-31 | Warnings, Adverse reactions | CASPOFUNGIN ACETATE CASPOFUNGIN ACETATE |
| Caspofungin Acetate | CASPOFUNGIN ACETATE | Gland Pharma Limited | 29da357e-e7fc-46af-bf20-806a1e4b5391 | 2022-01-19 | Warnings, Adverse reactions | Caspofungin Acetate CASPOFUNGIN ACETATE |
Reported adverse events (FAERS/openFDA)#
Adverse event summaries are temporarily unavailable. Other product information remains available.
NDC Listings For This Application#
| NDC | Name | Nonproprietary name | Labeler | Marketing category | Status |
|---|---|---|---|---|---|
| 69097-365 | caspofungin acetate | caspofungin acetate | Cipla USA Inc. | ANDA | Current |
| 69097-365 | caspofungin acetate | caspofungin acetate | Cipla USA Inc. | ANDA | Current |
| 69097-366 | caspofungin acetate | caspofungin acetate | Cipla USA Inc. | ANDA | Current |
| 69097-366 | caspofungin acetate | caspofungin acetate | Cipla USA Inc. | ANDA | Current |